July 2022 tender notification

Medicines Tender Closed

Pharmac is pleased to provide the latest tender results.

Tender results

Pharmac has resolved to award tenders for Principal Supply Status for some products included in the 2021/22 Invitation to Tender, dated 1 November 2021.

Some of the pharmaceuticals that will be delisted when the period of Principal Supply Status commences may be subject to existing listing contracts with Pharmac. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. Pharmac will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to Pharmac, the Pharmacy Guild and the NZULM by:

  • For new listings, by 4pm on 12 August 2022 or the 5th of the month prior to listing, whichever is earlier
  • For price changes, by 4pm on the 12th of the month prior to the date of subsidy change

Pharmac cannot list a product (and pharmacies cannot claim) without this information. 

More information about this process and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link)  and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link).

Pharmacodes and CTPP codes must be provided to Pharmac by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest).

Pharmac cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2021/22 Tender – Principal Supply Status applies until 30 June 2025

Community Pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1.  Tenders awarded to Pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Principal Supply brand (Supplier)

Date of listing

Principal Supply Status date

Brand
(Supplier)
affected by delisting

Domperidone

Tab 10 mg; 100 tablet blister pack

$2.85

$4.00

Domperidone Viatris (Viatris)

1 February 2023

1 July 2023

Pharmacy Health
(API Consumer brands)

Fluoxetine hydrochloride

Cap 20 mg; 90 capsule blister pack

$2.91 (per

84 capsules)

$3.13

Arrow – Fluoxetine (Teva)

1 January 2023

1 June 2023

Fluox
(Viatris)

Fluoxetine hydrochloride

Tab dispersible 20 mg, scored; 28 tablet blister pack

$1.84

$2.50

Fluox (pharmacode 2618575) (Viatris)

1 September 2022

1 February 2023

Fluox (pharmacode 2077817)
(Viatris)

Pantoprazole

Tab EC 20 mg; 90 tablet bottle

$2.02 (per

100 tablets)

$1.99

Panzop Relief (Viatris)

1 February 2023

1 July 2023

Panzop Relief (pharmacode 2496216)
(Viatris)

Pantoprazole

Tab EC 40 mg; 90 tablet bottle

$2.85 (per

100 tablets)

$2.74

Panzop Relief (Viatris)

1 February 2023

1 July 2023

Panzop Relief (pharmacode 2496224)
(Viatris)

Posaconazole

Tab modified-release 100 mg; 24 tablet blister pack

$869.86

$206.00

Posaconazole Juno (Juno)

1 November 2022

1 April 2023

Noxafil
(MSD)

Sertraline

Tab 50 mg; 30 tablet blister pack

$0.92

$0.99

Setrona (Douglas)

1 November 2022

1 April 2023

Setrona AU (Douglas)

Sertraline

Tab 100 mg; 30 tablet blister pack

$1.61

$1.74

Setrona (Douglas)

1 November 2022

1 April 2023

Setrona AU (Douglas)

Water

Inj 10 ml ampoule; 50 ampoule pack

$7.19

$7.60

Multichem (Multichem)

1 April 2023

1 September 2023

Pfizer
(Pfizer)

 

Hospital Pharmaceutical tenders – Section H of the Pharmaceutical Schedule.

2.  Tenders awarded to Pharmaceuticals where no other brand is listed

Chemical name

Presentation;
Pack size and type

Current
pack price

New
pack price

Principal Supply brand
(Supplier)

DV
limit

Date of price change

Principal Supply date

Sertraline

Tab 50 mg; 30 tablet blister pack

$0.92

$0.99

Setrona (Douglas)

5%

1 November 2022

1 April 2023

Sertraline

Tab 100 mg; 30 tablet blister pack

$1.61

$1.74

Setrona (Douglas)

5%

1 November 2022

1 April 2023

 

3.  Tenders awarded to Pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name

Presentation;
Pack size and type

Current pack price

New pack price

Principal Supply brand (Supplier)

DV Limit

Listing date

Principal Supply Status date

Brand
(Supplier)
affected by delisting

Domperidone

Tab 10 mg; 100 tablet blister pack

$2.85

$4.00

Domperidone Viatris (Viatris)

5%

1 February 2023

1 July 2023

Pharmacy Health

(API Consumer brands)

Fluoxetine hydrochloride

Cap 20 mg; 90 capsule blister pack

$2.91 (per

84 capsules)

$3.13

Arrow – Fluoxetine (Teva)

5%

1 January 2023

1 June 2023

Fluox
(Viatris)

Fluoxetine hydrochloride

Tab dispersible 20 mg, scored; 28 tablet blister pack

$1.84

$2.50

Fluox (pharmacode 2618575) (Viatris)

5%

1 September 2022

1 February 2023

Fluox (pharmacode 2077817) (Viatris)

Ondansetron

Inj 2 mg per ml, 2 ml ampoule; 5 ampoule pack

$1.50

$1.42

Ondansetron-AFT (AFT)

5%

1 October 2022

1 March 2023

Ondansetron-Baxter (Baxter)

Ondansetron

Inj 2 mg per ml, 4 ml ampoule; 5 ampoule pack

$2.20

$1.89

Ondansetron-AFT (AFT)

5%

1 October 2022

1 March 2023

Ondansetron Kabi (Fresenius Kabi)

Pantoprazole

Tab EC 20 mg; 90 tablet bottle

$2.02 (per

100 tablets)

$1.99

Panzop Relief (Viatris)

5%

1 February 2023

1 July 2023

Panzop Relief (pharmacode 2496216) (Viatris)

Pantoprazole

Tab EC 40 mg; 90 tablet bottle

$2.85 (per

100 tablets)

$2.74

Panzop Relief (Viatris)

5%

1 February 2023

1 July 2023

Panzop Relief (pharmacode 2496224) (Viatris)

Piperacillin with tazobactam

Inj 4 g with tazobactam 0.5 g vial; 1 vial pack

$38.00 (per 10 vials)

$3.59

PipTaz-AFT (AFT)

5%

1 September 2022

1 February 2023

PipTaz Sandoz (Sandoz)

PiperTaz Sandoz (Sandoz)

Posaconazole

Tab modified-release 100 mg; 24 tablet blister pack

$869.86

$206.00

Posaconazole Juno (Juno)

5%

1 November 2022

1 April 2023

Noxafil
(MSD)

Water

Inj 10 ml ampoule; 50 ampoule pack

$7.19

$7.60

Multichem (Multichem)

5%

1 April 2023

1 September 2023

Pfizer
(Pfizer)

Tender declines - Products where no tender is to be awarded for Principal Supply Status

Pharmac has resolved not to award tenders for Principal Supply Status for the following products listed in the:

  • 2020/21 Invitation to Tender, dated 2 November 2020

Chemical name

Line item

Fenofibrate

Cap/tab 48 mg

Fenofibrate

Cap/tab 145 mg

For products included in the 2019/20, 2020/21 or 2021/22 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to Pharmac Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made. 

If you have any queries regarding this notification, please contact Pharmac on 0800 66 00 50.